There were no apparent expression differences related to grade, lymph node involvement, estrogen or progesterone receptor status, HER2 status or donor age; however, there appeared to be a threshold tumour size after which RBM6-RBM5 chimeric transcript expression was detectable (Table 2). The gene discussed is PGR; the disease is neoplasm.